We are live on ! Find out more
NSRI

New Silk Road Investment Portfolio holdings

AUM $50.4M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
+32.31%
3 Year Est. Return
-21.21%
5 Year Est. Return
+10.41%
10 Year Est. Return
AUM
$277M
AUM Growth
+$10.8M
Cap. Flow
+$27.7M
Cap. Flow %
9.99%
Top 10 Hldgs %
97.98%
Holding
13
New
3
Increased
3
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$15.7M
2
BABA icon
Alibaba
BABA
+$7.96M
3
EDU icon
New Oriental
EDU
+$5.57M
4
WB icon
Weibo
WB
+$4.53M
5
HTT
High Templar Tech Ltd
HTT
+$2.62M

Top Sells

Rank Stock Value
1
BZUN
Baozun
BZUN
+$4.52M
2
YUMC icon
Yum China
YUMC
+$2.82M
3
UXIN
Uxin Ltd
UXIN
+$913K
4
HDB icon
HDFC Bank
HDB
+$446K
5
LX
LexinFintech Holdings
LX
+$227K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 63.01%
2 Financials 15.67%
3 Communication Services 11.02%
4 Healthcare 5.52%
5 Technology 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$293B
$122M 44.09%
721,099
+46,117
+7% +$7.96M
HDB icon
2
HDFC Bank
HDB
$122B
$34.9M 12.6%
1,074,400
-14,800
-1% -$446K
WB icon
3
Weibo
WB
$1.99B
$30.5M 11.02%
700,911
+80,835
+13% +$4.53M
YUMC icon
4
Yum China
YUMC
$16.5B
$28.4M 10.24%
614,231
-65,013
-10% -$2.82M
MMYT icon
5
MakeMyTrip
MMYT
$5.27B
$18.1M 6.52%
727,972
+18,879
+3% +$477K
ONC
6
BeOne Medicines Ltd
ONC
$32.5B
$15.3M 5.52%
+123,375
New +$15.7M
INFY icon
7
Infosys
INFY
$48.4B
$7.27M 2.62%
679,300
EDU icon
8
New Oriental
EDU
$9.34B
$6.01M 2.17%
+62,200
New +$5.57M
BZUN
9
Baozun
BZUN
$167M
$5.99M 2.16%
120,105
-104,795
-47% -$4.52M
LX
10
LexinFintech Holdings
LX
$239M
$2.88M 1.04%
257,800
-18,200
-7% -$227K
HTT
11
High Templar Tech Ltd
HTT
$376M
$2.86M 1.03%
+380,800
New +$2.62M
FINV
12
FinVolution Group
FINV
$1.15B
$2.75M 0.99%
632,150
-40,850
-6% -$201K
UXIN
13
Uxin Ltd
UXIN
$308M
-2,408
Closed -$913K

Similar funds

New Silk Road Investment's Q2 2019 Portfolio in Review

As of Q2 2019, New Silk Road Investment held 13 positions worth $277M, up 4% from $266M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

New Silk Road Investment deployed $27.7M of net new capital in Q2 2019, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was BeOne Medicines Ltd: 123,375 shares worth $15.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, down from 69% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Baozun, an estimated $4.52M trimmed.

  • New Silk Road Investment's largest Q2 2019 buy was BeOne Medicines Ltd: 123,375 shares worth $15.3M.
  • New Silk Road Investment added most to Alibaba in Q2 2019, an estimated $7.96M increase.
  • New Silk Road Investment's biggest Q2 2019 reduction was Baozun, cutting an estimated $4.52M.
  • New Silk Road Investment fully exited Uxin Ltd in Q2 2019, selling an estimated $913K.
  • New Silk Road Investment's ten largest holdings make up 98% of its $277M portfolio in Q2 2019.
  • New Silk Road Investment opened 3 new positions and closed 1 in Q2 2019.
  • New Silk Road Investment's portfolio value rose 4% quarter-over-quarter to $277M.

Based on New Silk Road Investment's 13F filing for Q2 2019, filed 31 Jul 2019.